India allows Foreign Direct Investment in most of the sectors via automatic route. The nod from FIPB in the Finance Ministry is required in certain sectors like pharmaceutical and defence, which are considered as sensitive areas.

At the forthcoming meeting, FIPB will also consider proposals of J P Morgan Asset Marketing (Asia), Touchstone Trust, Blue Star Infotech, Aurbindo Pharma, Hospira Pte Ltd, Sai Life Sciences, Mylan Laboratories Ltd, Centurion  laboratories and Montblanc Services BV, and others.

Recently, the government has taken several steps to boost FDI inflow into the country. It has de-licensed several defence products for private players, besides hiking the foreign investment cap to 49 percent in the sector.

Last month, the government approved promulgation of an Ordinance to hike FDI cap in the insurance sector to 49 percent from 26 percent, as the legislation could not be passed in the winter session of Parliament.

Latest News from India News Desk